These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21297466)

  • 1. Dyslipidemia and lipid management in HIV-infected patients.
    Lo J
    Curr Opin Endocrinol Diabetes Obes; 2011 Apr; 18(2):144-7. PubMed ID: 21297466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid management in patients who have HIV and are receiving HIV therapy.
    Aberg JA
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):207-22. PubMed ID: 19217520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical management considerations for dyslipidemia in HIV-infected individuals.
    Kirchner JT
    Postgrad Med; 2012 Jan; 124(1):31-40. PubMed ID: 22314112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenofibrate in the treatment of dyslipidemia associated with HIV infection.
    Samineni D; Fichtenbaum CJ
    Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):995-1004. PubMed ID: 20604734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of lipid disorders in patients living with HIV.
    Myerson M; Malvestutto C; Aberg JA
    J Clin Pharmacol; 2015 Sep; 55(9):957-74. PubMed ID: 25651539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid metabolism in treated HIV Infection.
    Dubé MP; Cadden JJ
    Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):429-42. PubMed ID: 21663837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection.
    Silverberg MJ; Leyden W; Hurley L; Go AS; Quesenberry CP; Klein D; Horberg MA
    Ann Intern Med; 2009 Mar; 150(5):301-13. PubMed ID: 19258558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyslipidemia in HIV-infected individuals.
    Sprinz E; Lazzaretti RK; Kuhmmer R; Ribeiro JP
    Braz J Infect Dis; 2010; 14(6):575-88. PubMed ID: 21340298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multimodal, evidence-based approach to achieve lipid targets in the treatment of antiretroviral-associated dyslipidemia: case report and review of the literature.
    Bain AM; White EA; Rutherford WS; Rahman AP; Busti AJ
    Pharmacotherapy; 2008 Jul; 28(7):932-8. PubMed ID: 18576908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence on the Protective Role of High-Density Lipoprotein (HDL) in HIV-Infected Individuals.
    Calmy A; Montecucco F; James RW
    Curr Vasc Pharmacol; 2015; 13(2):167-72. PubMed ID: 24188489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyslipidemia in HIV patients.
    Tungsiripat M; Aberg JA
    Cleve Clin J Med; 2005 Dec; 72(12):1113-20. PubMed ID: 16392725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders.
    Bednasz C; Luque AE; Zingman BS; Fischl MA; Gripshover BM; Venuto CS; Gu J; Feng Z; DiFrancesco R; Morse GD; Ma Q
    Curr Vasc Pharmacol; 2016; 14(3):280-7. PubMed ID: 26733388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of dyslipidemia in patients with human immunodeficiency virus.
    Shalit P
    Rev Cardiovasc Med; 2014; 15 Suppl 1():S38-46. PubMed ID: 24987862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summaries for patients. Response to cholesterol-lowering drugs in patients with and without HIV infection.
    Ann Intern Med; 2009 Mar; 150(5):I38. PubMed ID: 19258553
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical controversies in lipid management.
    Tziomalos K
    Panminerva Med; 2015 Jun; 57(2):65-70. PubMed ID: 25669164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipid alterations and cardiovascular risk associated with antiretroviral therapy].
    Masiá-Canuto M; Bernal-Morell E; Gutiérrez-Rodero F
    Enferm Infecc Microbiol Clin; 2006 Dec; 24(10):637-48. PubMed ID: 17194390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid management in human immunodeficiency virus.
    Myerson M
    Cardiol Clin; 2015 May; 33(2):277-98. PubMed ID: 25939300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New trials in the scene of cardiovascular disease: innovation, controversy, and reassurance.
    Badimon L
    Cardiovasc Res; 2021 Mar; 117(4):e52-e54. PubMed ID: 33615348
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of statins in the setting of HIV infection.
    Eckard AR; McComsey GA
    Curr HIV/AIDS Rep; 2015 Sep; 12(3):305-12. PubMed ID: 26126687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of metabolic complications and cardiovascular risk in HIV-infected patients.
    Blanco F; San Román J; Vispo E; López M; Salto A; Abad V; Soriano V
    AIDS Rev; 2010; 12(4):231-41. PubMed ID: 21179187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.